Literature DB >> 1310383

Signet-ring cell carcinoma of the prostate.

K M Alline1, M B Cohen.   

Abstract

We report an intriguing case of signet-ring cell carcinoma of the prostate, ie, a rare histopathologic pattern of prostatic carcinoma. We present the results of histologic, immunohistologic, and electron microscopic examinations in our case, and we compare the findings with those of cases that have been previously reported. Although the histopathologic findings in the rare cases of signet-ring cell carcinoma of the prostate thus far reported have varied greatly, the following conclusions can be made: (1) signet-ring cell carcinoma of the prostate is a high-grade carcinoma; (2) a prostatic primary should be considered in cases of metastatic signet-ring cell carcinoma, especially when results of gastrointestinal studies are unelucidating; and (3) staining for mucin, lipid, prostate-specific antigen, prostate-specific acid phosphatase, and carcinoembryonic antigen is variable.

Entities:  

Mesh:

Year:  1992        PMID: 1310383

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

Review 1.  Primary signet ring cell carcinoma of the prostate.

Authors:  Jonathan N Warner; Leah Y Nakamura; Anna Pacelli; Mitchell R Humphreys; Erik P Castle
Journal:  Mayo Clin Proc       Date:  2010-12       Impact factor: 7.616

Review 2.  The pathology of unusual subtypes of prostate cancer.

Authors:  Jing Li; Zhe Wang
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

3.  Diagnosis and Management of Primary Prostatic Signet Ring Cell Carcinoma: Single-Center Experience.

Authors:  Pu Li; Zihan Zhou; Meiling Bao; Jie Li; Xiaoxin Meng; Bianjiang Liu; Min Tang
Journal:  Am J Mens Health       Date:  2022 Mar-Apr

4.  Immunohistochemical analysis of PD-L1 and tumor-infiltrating immune cells expression in the tumor microenvironment of primary signet ring cell carcinoma of the prostate.

Authors:  Qi-Liang Teng; Xin-Rui Yang; Shuang Wen; Zhi-Hong Dai; Hong-Long Wang; Tian-Qing Liu; Liang Wang; Bo Fan; Zhi-Yu Liu
Journal:  Asian J Androl       Date:  2022 Sep-Oct       Impact factor: 3.054

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.